Janus Henderson Group’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$675K Buy
220,309
+82,100
+59% +$317K ﹤0.01% 1868
2025
Q4
$565K Hold
138,209
﹤0.01% 1970
2025
Q3
$674K Buy
138,209
+28,481
+26% +$150K ﹤0.01% 1864
2025
Q2
$555K Hold
109,728
﹤0.01% 1895
2025
Q1
$638K Buy
109,728
+26,100
+31% +$190K ﹤0.01% 1832
2024
Q4
$565K Hold
83,628
﹤0.01% 1975
2024
Q3
$552K Hold
83,628
﹤0.01% 1984
2024
Q2
$626K Buy
83,628
+21,206
+34% +$185K ﹤0.01% 1871
2024
Q1
$621K Buy
62,422
+25
+0% +$278 ﹤0.01% 1906
2023
Q4
$614K Sell
62,397
-109
-0.2% -$777 ﹤0.01% 1893
2023
Q3
$478K Buy
62,506
+96
+0.2% +$958 ﹤0.01% 1940
2023
Q2
$466K Buy
62,410
+41,026
+192% +$287K ﹤0.01% 2017
2023
Q1
$143K Buy
+21,384
New +$170K ﹤0.01% 2569
2022
Q3
Sell
-10,162
Closed -$83K 2593
2022
Q2
$83K Buy
+10,162
New +$68K ﹤0.01% 2502

Other funds holding RXRX